期刊文献+

二甲双胍对人肝癌细胞Bel-7402增殖与凋亡的影响

Effects of metformin on proliferation and apoptosis of human hepatocelluar carcinoma cell line Bel-7402
下载PDF
导出
摘要 目的:研究二甲双胍抑制人肝癌细胞Bel-7402增殖及调亡的影响,并初步探讨其机制。方法:体外培养人肝癌细胞株Bel-7402,以不同浓度的二甲双胍(10mM、20mM、40mM)干预细胞48h。采用MTT法检测药物对细胞增殖的影响;采用Hoechst 33258荧光染色法和流式细胞术检测细胞凋亡;Real-time PCR检测caspase-3、bax和bcl-2的mRNA水平表达。结果:与对照组相比,不同浓度的二甲双胍作用于Bel-7402细胞48h后,MTT结果显示对细胞增殖有明显抑制作用(P<0.05);Hoechst 33258荧光染色法显示凋亡细胞明显增多;流式细胞术分析显示二甲双胍可明显诱导Bel-7402细胞凋亡,晚期凋亡率分别为3.76%,8.96%和18.67%;caspase-3、bax和bcl-2的mRNA表达水平均上调(P<0.05);以上结果均具有浓度依赖性。结论:二甲双胍能抑制Bel-7402细胞增殖并诱导其凋亡,其机制可能与caspase-3、bax和bcl-2的mRNA表达水平改变有关。 Objective: To investigate the effects of metformin on proliferation and apoptosis in human hepatocelluar carcinoma cell line Bel-7402. Methods: Human hepatocelluar carcinoma cell line Bel-7402 were cultured in vitro and were treated with metformin (10 mM, 20 mM, 40 mM) for 48 h. The growth inhibition rates of Bel-7402 cells were measured by MTT assay. The ceil apoptosis was measured by Hoechst33258 staining and flow cytometry. The expression levels of caspase-3, tax and bcl-2 mRNA were detected by real-time PCR. Results: Metformin (10 mM, 20 mM, 40 mM) markedly deceased the proliferation of Bel-7402 in a dose-dependent manner (P%0. 05 vs. control). Metformin had obvious apoptosis-inducing activity on Bel-7402 cells. The rates of late apoptotic cells increased to 8. 6 %, 10.5 %, 15.2%, respectively. The expression levels of m spase-3, bax and &'l-2 mRNA were upregulated in a dose-dependent manner (P〈0. 05 vs. control). Conclusion: Metformin could inhibit the growth and induce apoptosis of Bel-7402 cells mainly via changing expression levels of related gene mRNA.
出处 《四川生理科学杂志》 2014年第1期14-17,共4页 Sichuan Journal of Physiological Sciences
关键词 二甲双胍 肝细胞癌 凋亡 Metformim Hepatocelluar carcinoma cell Apoptosis
  • 相关文献

参考文献4

二级参考文献21

  • 1Zhou G,Myers R,Li Y,Chen Y,Shen X,Judy F M,et al. Role of AMP activated protein kinase in mechanism of metformin action[J]. J Clin Invest, 2001,108 : 1167-1174.
  • 2Motoshima H,Goldstein B J,Igata M,Araki E. AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer[J].J Physiol,2006,574(Pt 1):63- 71.
  • 3Zakikhani M, Dowling R, Fantus I G, Sonenberg N, Pollak M. Metformin is an AMP kinase dependent growth inhibitor for breast cancer cells[J]. Cancer Res, 2006,66 : 10269-10273.
  • 4Ben S, I, Le Marchand Brustel Y, Tanti J F, Bost F. Metformin in cancer therapy: a new perspective for an old antidiabetic drug [J]? Mol Cancer Ther,2010,9 : 1092-1099.
  • 5Evans J M,Donnelly L A,Emslie-Smith A M,Alessi D R,Morris A D. Metformin and reduced risk of cancer in diabetic patients[J]. BMJ, 2005,330 : 1304-1305.
  • 6Bowker S L, Majumdar S R, Veugelers P, Johnson J A. Increased cancer related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: response to Farooki and Schneider[J].Diabetes Care, 2006,29 : 1990 -1991.
  • 7Donadon V,Balbi M,Mas M D,Casarin P,Zanette G. Metformin and reduced risk of hepatocellular carcinoma in diabetic pa tients with chronic liver disease[J]. Liver Int,2010,30:750 -758.
  • 8Davila J A,Morgan R O,Shaib Y,McGlynn K. A,EbSerag H B. Diabetes increases the risk of hepatocellular carcinoma in the U nited States: a population based case control study[J].Gut 2005,54:533-539.
  • 9Fabregat I, Roncero C, Fernandez M. Survival and apoptosis: a dysregulated balance in liver cancer[J].Liver Int, 2007,27:155 162.
  • 10Kirpichnikov D, McFarlane SI, Sowers JR. Mefformin: an update [J]. Ann Intern Med, 2002, 137(1) : 25 -33.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部